On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy

References

• Deckert T, Poulsen J E, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death and complications. Diabetologia 1978; 14: 363–70
   PubMed Web of Science ®Google Scholar
• Andersen A R, Christiansen J S, Andersen J K, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496–501
   PubMed Web of Science ®Google Scholar
• Parving H-H, Smidt U M, Friisberg B, Bonnevie-Nielsen V, Andersen A R. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981; 20: 457–61
   PubMed Web of Science ®Google Scholar
• Parving H-H, Andersen A R, Smidt U M, Oxenbøll B, Edsberg B, Christiansen J S. Diabetic nephropathy and arterial hypertension. Diabetologia 1983; 24: 10–2
   PubMed Web of Science ®Google Scholar
• Mauer S M, Steffes M W, Azar S, Sandberg S K, Brown D M. The effect of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 1978; 27: 738–44
   PubMed Web of Science ®Google Scholar
• Hasslacher C H, Stech W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1985; 28: 6–11
   PubMed Web of Science ®Google Scholar
• Mogensen C E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685–8
   PubMed Web of Science ®Google Scholar
• Parving H-H, Andersen A R, Smidt U M, Svendsen P Aa. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; i: 1175–9
   Google Scholar
• Björck S, Nyberg G, Mulec H, Grancrus G, Herlitz H, Aurello M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471–4
   PubMed Web of Science ®Google Scholar
• Parving H-H, Andersen A R, Smidt U M, Hommel E, Mathiesen E R, Svendsen P Aa. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443–7
   PubMed Web of Science ®Google Scholar
• Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643–51
   PubMed Web of Science ®Google Scholar
• Ladegaard-Pedersen H J. Measurements of extracellular volume and renal clearance by a single injection of insulin. Scand J Clin Lab Invest 1972; 29: 145–53
   PubMed Web of Science ®Google Scholar
• Bröchner-Mortensen J. Glomerular filtration rate and extracellular fluid volumes during normogly-caemia and moderate hyperglycaemia in diabetics. Scand J Clin Lab Invest 1973; 32: 311–6
   PubMed Web of Science ®Google Scholar
• Brochner-Mortensen J. Current status on assessment of glomerular filtraton rate. Clin Physiol 1985; 5: 1–17
   PubMedGoogle Scholar
• Christensen C, Ørskov H. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabetic Nephropathy 1984; 3: 92–4
   Google Scholar
• Schiøler V, Damkjær Nielsen M, Kappelgaard A M, Giese J. Partial purification of human renin substrate. Eur J Clin Invest 1976; 6: 229–40
   PubMed Web of Science ®Google Scholar
• Giese J, Damkjaer Nielsen M, Kappelgaard A M. Concentrations of active and inactive renin in human plasma: concepts and methodology. Heterogeneity of Renin and Renin-Substrate, M P Sambhi. Elsevier, AmsterdamHolland 1981; 205–13
   Google Scholar
• Rasmussen S, Damkjasr Nielsen M, Giese J. Captopril combined with thiazide lower renin substrate concentration: implications for methodology in renin assays. Ciin Sci 1981; 60: 590–3
   Google Scholar
• Kapplegaard A M, Damkjser Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67: 299–306
   Google Scholar
• Bruun N E, Ibsen H, Damkjaer Nielsen M, Mølbak A-G, Hartling O J. Lack of effect of Nifedipine on counterregulatory mechanisms in essential hypertension. Hypertension 1986; 8: 655–61
   PubMedGoogle Scholar
• Schütten H J, Johannessen A C, Torp-Pedersen C, Jensen K S, Bie P, Warberg T. Central venous pressure–A physiological stimulus for secretion of atrial natriuretic peptide in humans?. Acta Physiol Scand 1987; 131: 265–72
   Google Scholar
• Mortensen H B. Quantitative determination of hemoglobin Ak. by thin-layer isoelectric focusing. J Chromatography 1980; 182: 325–33
   PubMed Web of Science ®Google Scholar
• Steiness J. Diabetic neuropathy. Vibration sense and abnormal tendon reflexes in diabetics. Acta Med Scand 1963; 189(Suppl. 173)394–413
   Google Scholar
• Levy K J. Nonparametric applications of Shaffer's extension of Dunnett's procedure. Am Stat 1980; 34: 99–102
   Google Scholar
• Feldt-Rasmussen B, Mathiesen E R, Deckert T, et al. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus. Dia-betologia 1987; 30: 610–7
   Google Scholar
• O'Hare J A, Ferriss J B, Brady D, Twormey B, O'Sullivan D J. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985; 7(Suppl. II)43–8
   Google Scholar
• Parving H-H, Munkgaard Rasmussen S. Trans-capillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics. Scand J Clin Lab Invest 1973; 32: 81–7
   PubMed Web of Science ®Google Scholar
• Brochner-Mortensen J. A simple single injection method for determination of the extracellular fluid volume. Scan J Clin Lab Invest 1980; 40: 567–73
   PubMed Web of Science ®Google Scholar
• Parving H-H, Noer J, Deckert T, et al. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 1976; 12: 161–6
   PubMed Web of Science ®Google Scholar
• O'Hare J A, Ferriss J B, Twormey B M, Gonggripp H, O'Sullivan D J. Changes in blood pressure, body fluid volumes, circulating angiotensin II and aldosterone with improved diabetic control. Clin Sci 1982; 63: 415–8
   PubMed Web of Science ®Google Scholar
• Gall M-A, Mathiesen E R, Hommel E, Skott P, Parving H-H. The effect of short-term strict metabolic control on kidney function and extracellular fluid volume in insulin-dependent diabetics with and without microalbuminuria (Abstract). Acta Endocrinol 1987; 115(Suppl. 282)15
   Google Scholar
• DeFronzo R A. The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165–71
   PubMed Web of Science ®Google Scholar
• Skøtt P, Mathiesen E R, Hommel E, Gall M-A, Bruun N E, Parving H-H. Glomerulo-tubular balance in insulin-dependent diabetics with and without albuminuria (Abstract). Acta Endocrinol 1987; 115(Suppl. 282)53
   Google Scholar
• Maack T, Camargo M JF, Kleinert H D, Laragh J H, Atlas S A. Atrial natriuretic factor: structure and functional properties. Kidney Int 1985; 27: 607–15
   PubMed Web of Science ®Google Scholar
• Shenker Y, Sider R S, Ostafin E A, Grekin R J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with oedema. J Clin Invest 1985; 76: 1684–7
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamafi T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–22
   PubMed Web of Science ®Google Scholar
• Bates E R, Shenker Y, Grekin R J. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155–61
   PubMed Web of Science ®Google Scholar
• Christlieb A R, Kaldany A, D'elia J A. Plasma renin activity and hypertension in diabetes mellitus. Diabetes 1976; 25: 969–74
   PubMed Web of Science ®Google Scholar
• Christlieb A R, Kaldany A, D'Elia J A, Williams G H. Aldosterone responsiveness in patients with diabetes mellitus. Diabetes 1978; 27: 732–7
   PubMed Web of Science ®Google Scholar
• Hommel E, Parving H-H, Mathiesen E R, Edsberg B, Damkjsr Nielsen M, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 293: 467–70
   PubMed Web of Science ®Google Scholar
• Christlieb A R. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976; 25: 268–74
   PubMed Web of Science ®Google Scholar